Int J Gastrointest Interv.
2022 Jan;11(1):42-45. 10.18528/ijgii210052.
Necrotizing pancreatitis in a COVID-19 patient managed with endoscopic AXIOS stent placement
- Affiliations
-
- 1Department of Radiology, Yale School of Medicine, New Haven, CT, USA
- 2Department of Internal Medicine, Maulana Azad Medical College, New Delhi, India
- 3Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
- 4Department of Radiology, Mayo Clinic, Jacksonville, FL, USA
- KMID: 2525564
- DOI: http://doi.org/10.18528/ijgii210052
Abstract
- As coronavirus disease 2019 (COVID-19) is a relatively novel infectious process, atypical presentations like acute pancreatitis (AP) are still being studied and a clear association between pancreatic injury and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has yet to be established. This makes the diagnosis and management of such conditions exceedingly difficult. Although several cases of severe AP with concurrent SARS-CoV-2 infection have been reported, to the best of our knowledge, ours is the first COVID-19 case to present with necrotizing pancreatitis and the first reported case requiring intervention for associated local complications.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Prevention of Pancreatitis after Endoscopic Papillectomy; Stent versus No Stent
- Acute Necrotizing Pancreatitis and Coronavirus Disease-2019 (COVID-19)
- Utility of Fully Covered Esophageal Metal Stent in Percutaneous Endoscopic Necrosectomy
- Recent Advances in Endoscopic Papillectomy for Ampulla of Vater Tumors: Endoscopic Ultrasonography, Intraductal Ultrasonography, and Pancreatic Stent Placement
- Medical treatments of necrotizing pancreatitis
